MannKind Corp
MNKD
#5943
Rank
A$1.71 B
Marketcap
A$5.57
Share price
-4.87%
Change (1 day)
-4.68%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): A-$0.10

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is A-$0.09964. In 2025 the company made an earnings per share (EPS) of A$0.02847 a decrease over its 2024 EPS that were of A$0.14.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.10-456.6%
2025A$0.02847-80%
2024A$0.14
2022A-$0.486.25%
2021A-$0.4628%
2020A-$0.36-7.41%
2019A-$0.38
2017A-$1.58-188.1%
2016A$1.79-128.31%
2015A-$6.3374.51%
2014A-$3.63-20.31%
2013A-$4.55-32.63%
2012A-$6.76-28.03%
2011A-$9.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.86-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$6.11-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$40.18-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.09-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$4.16-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$11.99 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA